Search Result "TKI."
Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy
Journal: Current Drug Metabolism
Volume: 18 Issue: 3 Year: 2017 Page: 199-206
Author(s): Ruiqing Wang,Chaoqin Zhong,Chen Zhang,Mingqiang Hua,Daoxin Ma
Understanding and Targeting the Epigenetic Regulation to OvercomeEGFR-TKIs Resistance in Human Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 18 Issue: 4 Year: 2023 Page: 506-516
Author(s):
In vivo PET Imaging of EGFR Expression: An Overview of Radiolabeled EGFR TKIs
Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 28 Year: 2022 Page: 2329-2342
Author(s):
Anti-Proliferative Role of the Tyrosine Kinase Inhibitors TKI-258 on Oral Squamous Cell Carcinoma In Vitro
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 6 Year: 2020 Page: 751-755
Author(s): Isadora C. Silveira,Anna CecÃlia D.M. Carneiro,Lorraine S. Hiss,VirgÃnia O. Crema
Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 33 Year: 2024 Page: 2631-2642
Author(s): Eleni P. Kotanidou,Vasiliki Rengina Tsinopoulou
Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma
Journal: Current Drug Discovery Technologies
Volume: 13 Issue: 2 Year: 2016 Page: 68-76
Author(s): Akash Verma, Akhil Chopra, Yeo W. Lee, Lavina D. Bharwani, Atasha B. Asmat, Dokeu B.A Aneez, Fazuludeen A. Akbar, Albert Y.H. Lim, Sanjay H. Chotirmall, John Abisheganaden
Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9 Issue: 3 Year: 2014 Page: 382-393
Author(s): Suresh Kumar,Ritesh Agrawal
Drug Combinatorial Therapies for the Treatment of KRAS Mutated Lung Cancers
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 23 Year: 2019 Page: 2128-2142
Author(s): Hao He,Chang Xu,Zhao Cheng,Xiaoying Qian,Lei Zheng
The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1284-1292
Author(s): Francesco Passiglia,Nele Van Der Steen,Luis Raez,Patrick Pauwels,Ignacio Gil-Bazo,Edgardo Santos,Daniele Santini,Giovanni Tesoriere,Antonio Russo,Giuseppe Bronte,Karen Zwaenepoel,Federico Cappuzzo,Christian Rolfo
SHP2 Inhibition Benefits Epidermal Growth Factor Receptor-mutated Non-Small Cell Lung Cancer Therapy
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 21 Issue: 11 Year: 2021 Page: 1314-1321
Author(s): Leiming Xia,Lu Wen,Siying Wang